We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
NextGen (NXGN) Solutions Support COVID-19 Vaccine Distribution
Read MoreHide Full Article
NextGen Healthcare, Inc. recently announced that it is lending support to the rollout of COVID-19 vaccines via its established and robust electronic health record (EHR) platform and integrated solutions. With respect to vaccine distribution, NextGen is fulfilling its role of being a trustworthy health information technology (IT) partner. The company — a leading provider of ambulatory-focused technology solutions — is working closely with clients, regulatory bodies and public health organizations in order to serve the healthcare community.
Notably, NextGen Enterprise is an end-to-end software platform that simplifies COVID-19 vaccine workflow. On the back of this platform, providers can execute important functions like informing patients needing follow-up doses, and federal and state vaccine registry submissions. Further, the platform helps providers to identify high-risk patients through the NextGen Population Health solution.
This announcement is likely to provide a boost to NextGen’s robust solutions portfolio.
More on the News
NextGen has been helping clients with tools necessary to treat patients, including virtual visits and online access, without any hindrance since the onset of the outbreak. The company has been doing this and preparing for vaccine distribution at the same time.
Given the depth of experience in vaccine workflow and documentation, NextGen remains focused on leveraging its advanced technology solutions to make this herculean humanitarian effort much easier.
There are a number of NextGen solutions that support COVID-19 vaccine distribution, which comprises NextGen Office, NextGen Patient Experience Platform and NextGen Enterprise Practice Management (PM).
Market Prospects
Per a report by Allied Market Research, the global HCIT market is expected to reach $297 billion at a CAGR of 13.2% during the 2016-2022 period. Rise in demand for quality healthcare services and solutions, and patient safety and care, proactive supportive government initiatives, and increase in acceptance of mHealth and telehealth practices are the primary factors driving the market. Further, growing adoption of smartphones and patient-doctor convenience are contributing to the market’s growth.
Recent Developments
This month, NexGen announced that its NextGen Health Data Hub (HDH) has been chosen by HI-BRIDGE HIE (health information exchange). This will enable HIE administrators to build rules-driven data exchange to facilitate automated routing of patient information across the group of care. Notably, NextGen HDH is a cloud-based HIE platform that lends support to secure sharing of patient health data from numerous sources.
Again, this month, the company announced that its client — Bridges Health Partners LLC — has managed to boost quality of patient care and attain value-based care financial goals throughout its wide network of 1,100 physicians with the aid of NextGen Population Health. Additionally, Bridges Health has exceeded its savings objectives (nearly $20 million) for two consecutive years.
Price Performance
Shares of this Zacks Rank #3 (Hold) company have gained 11.9% in a year’s time, compared with the industry’s rally of 26.3%.
Merit Medical has a projected long-term earnings growth rate of 12.6%.
Patterson Companies has an estimated long-term earnings growth rate of 9.6%.
McKesson has a projected long-term earnings growth rate of 6.6%.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
Image: Bigstock
NextGen (NXGN) Solutions Support COVID-19 Vaccine Distribution
NextGen Healthcare, Inc. recently announced that it is lending support to the rollout of COVID-19 vaccines via its established and robust electronic health record (EHR) platform and integrated solutions. With respect to vaccine distribution, NextGen is fulfilling its role of being a trustworthy health information technology (IT) partner. The company — a leading provider of ambulatory-focused technology solutions — is working closely with clients, regulatory bodies and public health organizations in order to serve the healthcare community.
Notably, NextGen Enterprise is an end-to-end software platform that simplifies COVID-19 vaccine workflow. On the back of this platform, providers can execute important functions like informing patients needing follow-up doses, and federal and state vaccine registry submissions. Further, the platform helps providers to identify high-risk patients through the NextGen Population Health solution.
This announcement is likely to provide a boost to NextGen’s robust solutions portfolio.
More on the News
NextGen has been helping clients with tools necessary to treat patients, including virtual visits and online access, without any hindrance since the onset of the outbreak. The company has been doing this and preparing for vaccine distribution at the same time.
Given the depth of experience in vaccine workflow and documentation, NextGen remains focused on leveraging its advanced technology solutions to make this herculean humanitarian effort much easier.
There are a number of NextGen solutions that support COVID-19 vaccine distribution, which comprises NextGen Office, NextGen Patient Experience Platform and NextGen Enterprise Practice Management (PM).
Market Prospects
Per a report by Allied Market Research, the global HCIT market is expected to reach $297 billion at a CAGR of 13.2% during the 2016-2022 period. Rise in demand for quality healthcare services and solutions, and patient safety and care, proactive supportive government initiatives, and increase in acceptance of mHealth and telehealth practices are the primary factors driving the market. Further, growing adoption of smartphones and patient-doctor convenience are contributing to the market’s growth.
Recent Developments
This month, NexGen announced that its NextGen Health Data Hub (HDH) has been chosen by HI-BRIDGE HIE (health information exchange). This will enable HIE administrators to build rules-driven data exchange to facilitate automated routing of patient information across the group of care. Notably, NextGen HDH is a cloud-based HIE platform that lends support to secure sharing of patient health data from numerous sources.
Again, this month, the company announced that its client — Bridges Health Partners LLC — has managed to boost quality of patient care and attain value-based care financial goals throughout its wide network of 1,100 physicians with the aid of NextGen Population Health. Additionally, Bridges Health has exceeded its savings objectives (nearly $20 million) for two consecutive years.
Price Performance
Shares of this Zacks Rank #3 (Hold) company have gained 11.9% in a year’s time, compared with the industry’s rally of 26.3%.
Stocks to Consider
Some better-ranked stocks from the broader medical space are Merit Medical Systems, Inc. (MMSI - Free Report) , Patterson Companies, Inc. (PDCO - Free Report) and McKesson Corporation (MCK - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Merit Medical has a projected long-term earnings growth rate of 12.6%.
Patterson Companies has an estimated long-term earnings growth rate of 9.6%.
McKesson has a projected long-term earnings growth rate of 6.6%.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>